The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Additional Listing

10 Jun 2019 07:00

RNS Number : 5786B
Fisher (James) & Sons plc
10 June 2019
 

 

10 June 2019

James Fisher and Sons plc ('the Company')

Additional Listing

 

 

Application has been made to the Financial Conduct Authority for the listing of and to the London Stock

Exchange for admission of 50,000 ordinary shares of 25 pence each (the "Shares"), in respect of a blocklisting ('New Ordinary Shares').

 

The New Ordinary Shares will be issued from time to time pursuant to the following share schemes:

 

 

Share scheme

No of shares allocated

James Fisher and Sons Savings Related Share Option Scheme

50,000

 

On exercise the shares will be issued credited as fully paid and will rank pari passu in all respects with the Company's existing ordinary shares in issue. It is expected that admission will become effective on 12 June 2019.

 

 

For enquiries:

 

 

Jim Marsh, Group General Counsel and Company Secretary

Tel. 01229 615 559

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ALSCKODPQBKDDAK

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.